Lehrstuhl für Innere Medizin IV

Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence (2019) Weber MA, Mahfoud F, Schmieder R, Kandzari DE, Tsioufis KP, Townsend RR, Kario K, et al. Journal article, Review article Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review (2019) Kiuchi MG, Esler MD, Fink GD, Osborn JW, Banek CT, Böhm M, Denton KM, et al. Journal article, Review article EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUES SEMAGLUTIDE AND LIRAGLUTIDE ON RENAL OUTCOMES - A POOLED ANALYSIS OF THE SUSTAIN 6 AND LEADER TRIALS (2019) Perkovic V, Bain S, Bakris G, Buse J, Idorn T, Mahaffey K, Marso S, et al. Conference contribution EFFECTS OF SEMAGLUTIDE AND LIRAGLUTIDE ON URINARY ALBUMIN-TO-CREATININE RATIO (UACR) - A POOLED ANALYSIS OF SUSTAIN 6 AND LEADER (2019) Perkovic V, Bain S, Bakris G, Buse J, Idorn T, Mahaffey K, Marso S, et al. Conference contribution EGFR LOSS WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE TREATMENT: DATA FROM SUSTAIN 6 AND LEADER (2019) Perkovic V, Bain S, Bakris G, Buse J, Gondolf T, Idorn T, Lausvig N, et al. Conference contribution Response by Mann et al to Letter Regarding Article, "Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease: Results From the LEADER Trial" (2019) Mann J, Fonseca V, Mosenzon O, Raz I, Goldman B, Idorn T, von Scholten BJ, Poulter NR Journal article, Note Chemokine CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute T Cell-Mediated Kidney Allograft Rejection (2019) Schiffer L, Wiehler F, Bräsen JH, Gwinner W, Greite R, Kreimann K, Thorenz A, et al. Journal article Assessment of Use and Preferences Regarding Internet-Based Health Care Delivery: Cross-Sectional Questionnaire Study (2019) Paslakis G, Fischer-Jacobs J, Pape L, Schiffer M, Gertges R, Tegtbur U, Zimmermann T, et al. Journal article Minimal change disease and focal segmental glomerulosclerosis (2019) Mueller-Deile J, Schenk H, Schiffer M Journal article Effects of the nitric oxide synthase inhibitor ronopterin (VAS203) on renal function in healthy volunteers (2019) Ott C, Bosch A, Winzer N, Friedrich S, Schinzel R, Tegtmeier F, Schmieder R Journal article